SCHEMBL7881997

SCHEMBL7881997

NC(N)=NC(=O)c1cc2cc(Cl)ccc2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.62
F3 P13726 1/20 0.62
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
SIRT1 Q96EB6 1/20 0.52
HRH4 Q9H3N8 4/20 0.51
HRH3 Q9Y5N1 2/20 0.51
FLT3 P36888 1/20 0.51
SMYD3 Q9H7B4 1/20 0.49
HRH1 P35367 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
GUSB P08236 4/20 0.48
NHERF1 O14745 2/20 0.48
PYGL P06737 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7879665 0.98 F7 (0.60) F7F3MEN1KMT2ANPC1
SCHEMBL8170116 0.87 F7 (0.57) F7F3MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL8692469 0.86 F7 (0.56) F7F3MEN1KMT2ANPC1
SCHEMBL7877880 0.85 F7 (0.55) F7F3MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL7873363 0.84 F7 (0.54) F7F3MEN1KMT2ANPC1
SCHEMBL26053459 0.83 F7 (0.68) F7F3MEN1KMT2ANPC1
SCHEMBL764543 0.82 F7 (0.72) F7F3MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL8689667 0.81 ALOX15 (0.52) F7F3MEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL8687078 0.80 F7 (0.56) F7F3MEN1KMT2ANPC1
SCHEMBL7878096 0.80 FLT3 (0.61) NPC1RAB9AHRH4HRH3FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114393-A ADMINISTERING A BENZOYLGUANIDINE COMPOUND ANTIPROTOZOA AGENT HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) 2000-09-05 US claimed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-6114393-A ADMINISTERING A BENZOYLGUANIDINE COMPOUND ANTIPROTOZOA AGENT HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) 2000-09-05 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed